Plaque Reversal With Early, Aggressive Lipid Lowering Therapy
NCT05783804 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-10-02
Summary
This study evaluates whether plaques in young patients with familial hypercholesterolemia (aged below 50 years) are susceptible to significant plaque regression with early, intensive lipid lowering therapy.
Conditions
- Coronary Artery Disease Progression
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Principal Investigators
-
Erik SG Stroes, MD, PhD · Amsterdam UMC, location AMC
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-07-07
- Primary Completion
- 2026-12-31
- Completion
- 2027-04-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment
NCT01200056 ·Status: COMPLETED ·Phase: PHASE4
-
Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography
NCT06863545 ·Status: RECRUITING ·Phase: NA
-
The Effect of Statin Treatment on Arterial Wall Inflammation as Assessed With 68Ga-DOTATATE PET-CT
NCT05730634 ·Status: COMPLETED ·Phase: NA
-
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
NCT01223586 ·Status: COMPLETED
-
Change in Plaque Characteristics With Atorvastatin
NCT00700037 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis
NCT00570752 ·Status: COMPLETED ·Phase: PHASE2
-
Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
NCT00368589 ·Status: COMPLETED
-
Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis
NCT06785974 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Early Atherosclerosis Change in Two Clinical Trials
NCT00005696 ·Status: COMPLETED
-
Effects of Short-term Intensive Statin Therapy on Lipid Levels
NCT07344610 ·Status: RECRUITING
-
Statins in Cerebral Blood Flow and Neuronal Activity--A Pilot Study
NCT03411291 ·Status: COMPLETED
-
Adverse Plaque Characteristics in CCTA and TVC Imaging
NCT02350959 ·Status: UNKNOWN ·Phase: PHASE4
-
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
NCT00920101 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
NCT00715273 ·Status: COMPLETED ·Phase: PHASE4
-
This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.
NCT00380939 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia
NCT00329069 ·Status: COMPLETED ·Phase: NA
-
Progression of Early Subclinical Atherosclerosis
NCT01410318 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Acute Statin Treatment in Patients Undergoing Percutaneous Coronary Intervention
NCT00588471 ·Status: TERMINATED ·Phase: NA
-
The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue
NCT00587717 ·Status: COMPLETED ·Phase: NA
-
Identification of CETP as a Marker of Atherosclerosis
NCT02081066 ·Status: COMPLETED ·Phase: NA
-
Assessment of Change in Atherosclerotic Plaque by Serial CCTA
NCT03414840 ·Status: UNKNOWN
-
Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)
NCT00979940 ·Status: TERMINATED ·Phase: NA
-
Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
NCT00703261 ·Status: COMPLETED ·Phase: PHASE1
-
Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)
NCT00242944 ·Status: COMPLETED ·Phase: PHASE4
-
Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
NCT00880178 ·Status: COMPLETED